在COVID-19流行病的第二波期间,ICD患者的腹腔失常负担
Benjamin Rath1, Florian Doldi2, Kevin Willy2
1Department of Cardiology II-Electrophysiology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany. benjamin.rath@ukmuenster.de.
概括
在第二波COVID-19期间,植入式除器 (ICD) 患者经历了需要ICD治疗的腹腔失律 (VA) 的显著增加,与早期的流行病发现形成鲜明对比.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- COVID-19与心血管问题有关,如腹腔失常 (VA) 和心脏骤停.
- 最初的报道表明,在COVID-19第一波期间,植入式除器 (ICD) 患者的VA负担下降.
- 关于大流行后期的VA趋势的不确定性仍然存在.
研究的目的:
- 调查第一波COVID-19期间观察到的减少VA负担是否持续到第二波.
- 与对照期相比,评估VA发生的变化,需要在第二波COVID-19浪潮期间进行ICD干预.
主要方法:
- 对1674名心脏病患者进行了回顾性分析.
- 在第二波COVID-19浪潮期间需要ICD干预的VA与对照期的比较.
- 在门诊诊所环境中进行的设备审讯.
主要成果:
- 在第二次COVID-19浪潮期间,观察到显著增加了充足的ICD疗法的数量.
- 在COVID-19期间,4.5%的患者接受了适当的ICD干预,而在对照期为1.8% (p=0.01).
- 在疫情期间,36名患者经历了持续的VA,需要ICD干预,而对照组的患者则为16人.
结论:
- 与第一波相反,第二次COVID-19浪潮在ICD患者中VA的显著增加.
- 潜在的促成因素包括增加的感染率,疫苗接种副作用,行为变化或减少医疗保健利用率.
- 这些发现强调了与COVID-19流行病相关的不断变化的心血管风险.
更多相关视频
16:40A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
26.3K
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.3K
相关概念视频
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
22
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
22
01:25Dysrhythmias VI: Management of Dysrhythmias
17
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
17
01:28Dysrhythmias II: Classification of Tachyarrhythmias
10
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
10
01:28Disturbances in Heart Rhythm
977
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
977
01:28Mechanism of Cardiac Arrhythmias
929
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
929
01:29Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14